CHOSA Oncology AB has carried out a directed issue of SEK 1,55 million to further increase business development activities
The board of CHOSA Oncology AB (publ) ("CHOSA" or the "Company") has today, 13[th] October 2023, performed a directed issue of 2 099 280 shares at a price of SEK 0,738 per share. The reason for the deviation from conducting a shareholders’ preferential rights issue has been to raise capital in a time-efficient manner. The subscription price per share has been set under market conform conditions based upon Volume Weighted Average Price (VWAP) over a period of 10 trading days up to and including 12. October 2023, which was the last trading day for the share before the Board of Director’s